Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$10.16
-2.6%
$11.10
$9.76
$19.22
$288.85M0.89313,924 shs152,512 shs
Fonar Corporation stock logo
FONR
Fonar
$15.57
+0.5%
$15.57
$12.00
$17.98
$96.53M0.9719,859 shs10,012 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$9.26
+1.3%
$9.33
$5.45
$18.98
$306.65M1.9270,665 shs155,901 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$13.56
-1.3%
$16.54
$5.85
$25.35
$240.09M2.13224,269 shs59,048 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-0.57%-1.97%+4.30%-19.71%-19.65%
Fonar Corporation stock logo
FONR
Fonar
-3.00%+0.65%-0.90%+7.27%-10.87%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-0.11%+1.90%+1.67%-30.60%+15.40%
Outset Medical, Inc. stock logo
OM
Outset Medical
-1.22%-2.55%-8.64%-28.88%+72.83%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.0887 of 5 stars
3.51.00.00.03.00.80.6
Fonar Corporation stock logo
FONR
Fonar
1.583 of 5 stars
0.03.00.00.02.70.81.9
NeuroPace, Inc. stock logo
NPCE
NeuroPace
3.8443 of 5 stars
3.45.00.00.03.63.30.6
Outset Medical, Inc. stock logo
OM
Outset Medical
1.5769 of 5 stars
3.51.00.00.03.20.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
3.00
Buy$19.6793.57% Upside
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.83
Moderate Buy$16.6079.36% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$24.6781.89% Upside

Current Analyst Ratings Breakdown

Latest FONR, OM, NPCE, and CLPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/19/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$22.00
8/13/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/13/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$17.00 ➝ $15.00
8/7/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$21.00 ➝ $22.00
8/1/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $9.00
7/14/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$37.00
(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$31.39M9.20N/AN/A$0.69 per share14.72
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.94$3.00 per share5.19$24.78 per share0.63
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$79.91M3.83N/AN/A$0.59 per share15.69
Outset Medical, Inc. stock logo
OM
Outset Medical
$113.69M2.12N/AN/A$8.50 per share1.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$18.91M-$0.81N/AN/AN/A-66.15%-94.44%-51.58%11/6/2025 (Estimated)
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2512.46N/A8.19%5.31%3.97%9/26/2025 (Estimated)
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$27.14M-$0.84N/AN/AN/A-29.29%-168.61%-25.48%11/11/2025 (Estimated)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$127.98M-$20.29N/AN/A-82.06%-97.17%-32.84%11/5/2025 (Estimated)

Latest FONR, OM, NPCE, and CLPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.20-$0.21-$0.01-$0.21$9.20 million$9.22 million
8/12/2025Q2 2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.24-$0.26-$0.02-$0.26$23.08 million$23.52 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
1.46
7.30
6.45
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
NeuroPace, Inc. stock logo
NPCE
NeuroPace
3.02
5.47
4.51
Outset Medical, Inc. stock logo
OM
Outset Medical
0.63
7.47
6.05

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Fonar Corporation stock logo
FONR
Fonar
50.64%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.11%
Fonar Corporation stock logo
FONR
Fonar
1.55%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
20.50%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11028.43 million26.69 millionOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17033.08 million26.30 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.77 million17.34 millionNot Optionable

Recent News About These Companies

GMT Capital Corp Cuts Stake in Outset Medical, Inc. $OM
Outset Medical’s Earnings Call Highlights Strong Growth
Outset Medical (OM) Receives a Hold from Oppenheimer
Outset Medical Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$10.16 -0.27 (-2.59%)
As of 03:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Fonar stock logo

Fonar NASDAQ:FONR

$15.57 +0.07 (+0.45%)
As of 03:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$9.26 +0.12 (+1.26%)
As of 03:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$13.56 -0.18 (-1.30%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.